CD8A and cancer: Alternatively—owing to its ability to induce proliferation and effector differentiation–strong and sustained IL-2 signals might be employed for immunotherapeutic interventions against cancers and chronic infections that rely on activation of a large pool of antigen-specific CD8 T cells.